by TractManager | Oct 20, 2022 | Emerging Technology Report
Trofinetide (formerly NNZ-2566) is an oral synthetic glypromate analog proposed for the treatment of classic Rett syndrome, a rare neurodevelopmental disorder.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Oct 18, 2022 | Precision Medicine Insights
This report reviews clinical study abstracts and clinical practice guidelines addressing comprehensive molecular profiling (CMP) of circulating solid tumor DNA as a broad molecular profiling tool to aid in decision making regarding biomarker-matched treatment...
by TractManager | Oct 18, 2022 | Emerging Technology Report
Pegcetacoplan is an investigational, intravitreally injected complement inhibitor proposed for the treatment of geographic atrophy secondary to age-related macular degeneration.If you have a Hayes login, click here to view the full report on the Knowledge...
by TractManager | Oct 18, 2022 | Precision Medicine Insights
This report reviews clinical study abstracts and clinical practice guidelines addressing comprehensive molecular profiling (CMP) of circulating solid tumor DNA as a broad molecular profiling tool to aid in monitoring for indicators of treatment response/failure or...
by TractManager | Oct 14, 2022 | Health Technology Assessment
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the safety and effectiveness of proton beam therapy (PBT) for the treatment of breast cancer with no distant metastasis. This HTA also compares the safety and effectiveness of PBT...
Recent Comments